Trauma, resilience and saliostasis: Effects of treatment in post-traumatic stress disorder

International Clinical Psychopharmacology

Volumn 20, Issue 1, 2005, Pages 43-48

  Davidson, Jonathan R T ^a,f   Payne, Victoria M ^a   Connor, Kathryn M ^a   Foa, Edna B ^d   Rothbaum, Barbara O ^e   Hertzberg, Michael A ^a,b   Weisler, Richard H ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c University of Pennsylvania ^*

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Post traumatic stress disorder; Resilience

Indexed keywords

FLUOXETINE; PSYCHOTROPIC AGENT; SERTRALINE; TIAGABINE;

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; COPING BEHAVIOR; DECISION MAKING; DEMOGRAPHY; DRUG EFFECT; FEMALE; HUMAN; HUMOR; INJURY; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RATING SCALE; SCORING SYSTEM; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADULT; COGNITIVE THERAPY; FEMALE; FLUOXETINE; GABA AGONISTS; HUMANS; MALE; MIDDLE AGED; NIPECOTIC ACIDS; PROGNOSIS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 12144249587     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200501000-00009     Document Type: Article

References (30)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
2. American Psychiatric Association (2000). Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association.
3. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
4. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JRT (1999). Fluoxetine in post-traumatic stress disorder: randomized, double-blind study. Br J Psychiatry 175:17-22.
5. Connor KM, Davidson JRT (2003). Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RSIC). Depress Anxiety 18:76-82.
6. Cousins N (1989) Head First, The Biology of Hope. New York, NY: Penguin Books, pp. 125-153.
7. Davidson J, Watkins L, Owens M, Dube E, Krulewicz S, Connor K, et al. (2003). Paroxetine and venlafaxine-XR: effects on heart rate variability and the role of norepinephrine transport inhibition. Presented at the European College of Neuropsychopharmacology, Prague, Czech Republic.
8. Davidson JRT, Book SW, Colket JT, Tupler LA, Roth S, David D, et al. (1997). Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med 27:153-160.
9. Davidson RJ (2000). Affective style, psychopathology, and resilience: brain mechanisms and plasticity. Am Psychol 55:1196-1214.
10. Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkrantz R, Muller D, Santorelli SF, et al. (2003). Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med 65:564-570.
11. Dienstbier RA (1991). Arousal and physiological toughness: implication for mental and physical health. Psychol Rev 96:81-100.
12. Duman RS, Malberg J, Thorne J (1999). Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46:1181-1191.
13. Escalona R, Tupler LA, Saur CD, Krishnan KRR, Davidson JRT (1997). Screening for trauma history on an inpatient affective-disorders unit: a pilot study. J Traum Stress 10:299-305.
14. Friedman MJ (2002). Future pharmacotherapy for post-traumatic stress disorder: prevention and treatment. Psychiatr Clin North Am 25:427-441.
15. Garmezey N (1985). Stress resistant children: the search for protective factors. Recent Research in Developmental Psychopathology. Oxford: Pergamon Press.
16. Garmezey N, Rutter M (1985). Acute stress reactions. In: Rutter M, Hersch L (editors): Child and Adolescent Psychiatry: Modern Approach. Oxford: Blackwell.
17. Harmer CJ, Cowen PJ, Goodwin GM (2002). Antidepressants and emotional processing. Neuropsychopharmacology 28:1384-1385.
18. Harmer CJ, Hill SA, Taylor MJ, Cowen PJ, Goodwin GM (2003). Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias and potentiation of norepinephrine activity. Am J Psychiatry 160:990-992.
19. Healy D, Healy H (1998). The clinical pharmacological profile of reboxetine: does it involve the putative neurobiological substrate for well being? J Affective Dis 51:313-322.
20. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JRT (2000). Lack of efficacy for fluoxetine in PTSD: a placebo-controlled trial in combat veterans. Ann Clin Psychiatry 12:101-105.
21. King LA, King DW, Fairbank JA, Keane TM, Adams GA (1998). Resilience-recovery factors in post-traumatic stress disorder among female and male Vietnam veterans: hardiness, postwar social support, and additional stressful life events. J Personality Soc Psychol 74:420-434.
22. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, et al. (1998). Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 155:373-379.
23. Kobasa SC (1979). Stressful life events, personality and health: an enquiry into hardiness. J Personal Soc Psychol 37:1-11.
24. Martin RA (2001). Humor, laughter, and physical health: methodological issues and research findings. Psychol Bull 127:504-519.
25. Morgan CA III, Wang S, Southwick SM, Rasmusson A, Hazlett G, Hauger RL, et al. (2000). Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry 47:902-909.
26. Morgan CA III, Rasmussen AM, Wang S, Hoyt G, Hauger RL, Hazlett G (2002). Neuropeptide-Y, cortisol and subjective distress humans exposed to acute stress replication and extension of previous report. Biol Psychiatry 52:136-142.
27. Ravindran AV, Griffiths J, Waddell C, Anisman H (1994). Stressful life events and coping styles in relation to dysthymia and major depressive disorder: variations associated with alleviation of symptoms following pharmacotherapy. Prog Neuro Psychopharmacol Biol Psychiatry 19:637-653.
28. Seligman ME (2000). Positive psychology: an introduction. Am Psychol 55:5-14.
29. Sheehan DV (1983). The Anxiety Disease. New York, NY: Bantam Books.
30. Tannenbaum B, Anisman H (2003). Impact of chronic intermittent challenges in stressor-susceptible and resilient strain of mice. Biol Psychiatry 53:292-303.